Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific P13K inhibitor in combination with fulvestrant: Results from a phase I study Meeting Abstract
| Authors: | Juric, D.; Gonzalez-Angulo, A. M.; Burris, H. A.; Schuler, M.; Schellens, J.; Berlin, J.; Gupta, A.; Seggewiss-Bernhardt, R.; Adamo, B.; Gil-Martin, M.; Bootle, D.; Boehm, M.; De Buck, S.; Demanse, D.; Quadt, C.; Baselga, J. |
| Abstract Title: | Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific P13K inhibitor in combination with fulvestrant: Results from a phase I study |
| Meeting Title: | 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 73 |
| Issue: | 24 Suppl. |
| Meeting Dates: | 2013 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2013-12-15 |
| Language: | English |
| ACCESSION: | WOS:000209496901063 |
| DOI: | 10.1158/0008-5472.sabcs13-p2-16-14 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2-16-14 -- Source: Wos |
